Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where are you seeing that?
I've always thought the ignore button was silly. One can't ever get enough knowledge and any 'post' is completely non-threatening.
Wade's problem is with LISTENING! He just can't seem to do it - He has a rebuttal to ANYTHING/EVERYTHING!
p.s. my game went up about 6 notches when I ceased paying him any mind...
AFIB - biobusts loaded with cash have been my go-to stocks for several years now. I do not like AFIB at above even $2.50 pps for anything other than a possible pumpndump bounce at which time I'd be looking to sell into that.
To the patient investor and as AFIB undoubtedly continues hemorrhaging cash, one could get this much cheaper as a secondary/s are in it's near future IMO
AFIB 3.33 - getting pummeled below book-value with large losses, poor guidance and chart looks destined for further downside imo.
https://docoh.com/news/benzinga/24049988/acutus-medical-reports?fromCompany=1522860
Anyone see anything to like here?
pump https://docoh.com/news/benzinga/23820575/aquabounty-technologies?fromCompany=1603978
n
dump https://docoh.com/news/benzinga/24187082/aquabounty-technologies?fromCompany=1603978
https://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=aqb&insttype=&freq=1&show=&time=5
How does a retail-outsider compete with such overt PROMISCUITY???
CPSS 9.39 - thanks again, nelson, as I should pay more attention to shareholder detail? CPSS management also appears to have a ton of stock options available at much lower pps's...so... glass-half-full - they ain't selling many.
Still holding - another (short-term) plus for CPSS is the scant possibility for any tax-loss-selling.
Are you still in? Anyone else still liking CPSS in the $9's?
Tax-loss-selling - we have 3 more weeks of possibility which today appears a probability as there'll be more downside to some of the absolute-chart-dogs such as AFI & TISI? Where to buy correctly???
A January bounce is kinda inevitable on most of these pummeled charts imo so I'll be looking at a bunch of em with emphasis on the biobusts...
maybe wade will join in on a PRODUCTIVE tax-loss-selling discussion, likely not...
or simply say, "Congrats Nelson, Hweb, Kik etc for a great trade..
fyi - wade has been on my ignore list for a few months now. He did this with BGFV also claiming it a strong-sell in the $2's. Why continue to engage?
in addition to congratulations, another PROPER response would be,
"I should have LISTENED better, sans BLABBING, to the SGMA dd provided here"
Thanks. Where are you looking because nasdaq.com isn't show Black Diamond at all?
https://www.nasdaq.com/market-activity/stocks/cpss/institutional-holdings
CPSS - BLACK DIAMOND CAPITAL MANAGEMENT, L.L.C.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,047,703 - 19.21%
Is this a brand new shareholder? Is this common?
https://docoh.com/filing/889609/0000905148-21-000722/CPSS-SC13D
SVRA 1.06 - add to the biobust list on strength of several Form4 filings...
BV 1.36 / Burn (.07)
https://docoh.com/search?q=0001160308
Group-head-fake or are insiders feeling a bargain at hand?
SVRA 1.06 - add to the biobust list on strength of several Form4 filings...
BV 1.36 / Burn (.07)
https://docoh.com/search?q=0001160308
Group-head-fake or are insiders feeling a bargain at hand?
CPSS - I did try to sell the Jan$10 calls at .70 but not even a nibble??
The broad market call-writing gravytrain from a few months back has really dried up. Reminds of a 3 amigos scene, "Now we have to use our brains"
CPSS 8.91 - holding on as I think it blows thru the previous high 8.97. Of all the stocks we've watched explode from sub10 to 20+, CPSS looks as primed as any, numbers, sector, etc.
Recent tout-sheet-8k in attempt to draw institutional investors appears to be working?
https://docoh.com/filing/889609/0001683168-21-006172/CPSS-8K/file/2
Phase 1 should be a gimme here according to past results but just so far away - so many expenses...
https://www.clinicaltrials.gov/ct2/show/results/NCT04396717?term=pritumumab&draw=2&rank=1&view=results
...and if/when they get past Phase 1, they'll need a ton more capital for expenses to continue which would likely require an R/S in this stock's future.
So, I see no hurry for any 'buy-n-hold' strategy here.
Ignore this post if the waning corona-kookout rears it's ugly head again...
From the NEJM link:
...The efficacy in preventing severe disease was 98.2% (95% CI, 92.8 to 99.6), with 2 cases in the mRNA-1273 group and 106 in the placebo group...
...A total of 32 deaths had occurred by completion of the blinded phase, with 16 deaths each (0.1%) in the placebo and mRNA-1273 groups; no deaths were considered to be related to injections of placebo or vaccine, and 4 were attributed to Covid-19 (3 in the placebo group and 1 in the mRNA-1273 group) (Tables S19 and S26)...
Did 103 "severe disease" cases in the placebo group fully recover or am I in confusion over specific dates??
https://www.nejm.org/doi/10.1056/NEJMoa2113017
SPRB 2.36 - added 2.25 (new low) this morning on the overall broad-market-flushout. Nice midday bounceback on most of the list of 14 and a possible END to this drip drip drip deluge??
https://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=sprb&insttype=&freq=1&show=&time=7
From the brownstone link...https://www.nejm.org/doi/10.1056/NEJMoa2113017
The argument you make is specious
I was unaware that I was making an argument. I thought I was asking if everyone here agreed with a specific definitive conclusion from a brand new website?
"The motive force of Brownstone Institute is the global crisis created by policy responses to the Covid-19 pandemic of 2020. That trauma revealed a fundamental misunderstanding alive in all countries around the world today, a willingness on the part of the public and officials to relinquish freedom and fundamental human rights in the name of managing a public health crisis, which was not in fact managed well in most countries. The consequences were devastating and will live in infamy."
https://brownstone.org/about/
Currently own (& adding as each are in freefall) 14 biobust stocks trading well below (mostly cash) Book Value. Seeking a January bounce off overdone tax-loss-selling? The list below is estimated including each stock's previous quarterly burnrate:
SYN .31 - BV .54 / Burn (.02)
CLBS .84 - BV 1.63 / Burn (.12)
ADVM 1.76 - BV 3.53 / Burn (.39)
GRAY 2.10 - BV 3.43 / Burn (.38)
ASMB 2.13 - BV 3.89 / Burn (.41)
SPRB 2.33 - BV 5.22 / Burn (.49) plunging
GLTO 2.40 - BV 5.20 / Burn (.50) plunging
HTBX 3.93 - BV 4.96 / Burn (.30)
TCRR 5.01 - BV 8.05 / Burn (.69)
RFL 5.35 - BV 6.52 / Burn (.38)
NXTC 5.72 - BV 8.86 / Burn (.65)
TARA 6.29 - BV 10.32 / Burn (.96)
SBTX 6.78 - BV 9.48 / Burn (.65)
LUMO 7.15 - BV 11.33 / Burn (.90)
Currently own (& adding as each are in freefall) 14 biobust stocks trading well below (mostly cash) Book Value. Seeking a January bounce off overdone tax-loss-selling? The list below is estimated including each stock's previous quarterly burnrate:
SYN .31 - BV .54 / Burn (.02)
CLBS .84 - BV 1.63 / Burn (.12)
ADVM 1.76 - BV 3.53 / Burn (.39)
GRAY 2.10 - BV 3.43 / Burn (.38)
ASMB 2.13 - BV 3.89 / Burn (.41)
SPRB 2.33 - BV 5.22 / Burn (.49) plunging
GLTO 2.40 - BV 5.20 / Burn (.50) plunging
HTBX 3.93 - BV 4.96 / Burn (.30)
TCRR 5.01 - BV 8.05 / Burn (.69)
RFL 5.35 - BV 6.52 / Burn (.38)
NXTC 5.72 - BV 8.86 / Burn (.65)
TARA 6.29 - BV 10.32 / Burn (.96)
SBTX 6.78 - BV 9.48 / Burn (.65)
LUMO 7.15 - BV 11.33 / Burn (.90)
In this sub-link from the 'brownstone' link, Table S26 on page 67 lists in detail the causes of death in vaccinated/placebo:
https://www.nejm.org/doi/suppl/10.1056/NEJMoa2113017/suppl_file/nejmoa2113017_appendix.pdf
Following a combined total of 74,580 individuals, half given the COVID-19 vaccination and half given a placebo shot, over six to seven months, the two studies reported that thirty-seven people who were vaccinated died as compared to thirty-three people who received placebo.
Simply put, the very best scientific evidence currently available to mankind does not support the widely held contention that COVID-19 vaccination using the Pfizer or Moderna brands lowers risk of death, at least over the first half-year after vaccination. Interestingly, these striking findings were not reported in the main body of the papers but in supplemental sections.
https://brownstone.org/articles/vaccine-mandates-unscientific-divisive-and-enormously-costly/
Now proceed to the chalkboard and type 100 times:
Pandemic of vaccinated-silent-carriers sneakinfecting with cheezy passports pretending they are squeaky clean.
Since no poster here has disputed the sentence quoted below, might we all assume it is 100% factual?
Following a combined total of 74,580 individuals, half given the COVID-19 vaccination and half given a placebo shot, over six to seven months, the two studies reported that thirty-seven people who were vaccinated died as compared to thirty-three people who received placebo.
https://brownstone.org/articles/vaccine-mandates-unscientific-divisive-and-enormously-costly/
Thx and I haven't seen any update on CPSS?
CPSS 7.30 - nice dip for rebuying...
APT 5.70 - getting dumped in premarket...not very encouraging for those thinking 'omicron' might advance further corona-kookout'isms?
Are you adding APT? I'll likely sell those 4 covid-plays I bought on Friday and await potential further tax-loss-selling...
From the Q3 pr:
TADFIN for the Treatment of Benign Prostatic Hyperplasia PDUFA Date is On Track for December 2021—
From the website (CURRENT) verbage:
The Company anticipates submitting an NDA for its Tad-Fin Combination Capsule under the 505(b)(2) regulatory pathway by the end of 2020...
...The Company plans to submit an NDA for TADFIN™ in very early calendar year 2021.
https://verupharma.com/pipeline/tadfin/
Hokie Dokie, ya think? It's one thing for a public-management to pile up the BS skyhigh but quite another that they don't even seem to care???
re: coronavirus'ES...I believe the covid-vaccines are in the bank (for what they're worth), masks likely do NOT help much, and the remaining stock prospects will be with therapeutics...
also added some TRVN...
APT 6.30 - shoulda bought the dip to $4's like I previously suggested...likelihood of ensuing 'virus-kookout's do seem to be in favor.
Not chasing APT here, but did buy a few covid plays still trading deep chart valleys, RIGL, HTBX, and NRBO...
A mathematical comparison. Another downside to owning SKAS is the miniscule volume which kinda dictates owning a small position only...
Just checking in to see if everyone is getting what they deserve...and more?
Still have bids in at a lower pps...
SKAS 3.85 - getting some interest today. Overall numbers appear superior to CYAN 3.10 with very similar numbers...except...SKAS maintains 1/6th the O/S.
Did you take $3's? I think we can get $4's or more...
SPRB 2.71 - nice, loading up my dinghy here at these cheap prices. I'm showing closer to $5 in tangible book (mostly cash) with a (.49) burn.
Looking forward, SPRB will likely still have $4-tangible-book value at the Q1 filing in May. Almost 6 months to try n catch a fat finger...
see GLTO - also loading my dinghy there with very similar numbers...
SKAS 3.98 - the recent 10-Q-filing shows:
As of November 15, 2021, the registrant had 1,028,863 shares of its common stock, $0.03 par value, issued and outstanding
Cash = 2,010,293
Total Liabilities = 900,244
They should utilize that rich cash reserve in the form of a one-time-dividend to light a fire under some apathetic kiesters? $.25 cents, $.50 cents even better...
SKAS 3.98 - the recent 10-Q-filing shows:
As of November 15, 2021, the registrant had 1,028,863 shares of its common stock, $0.03 par value, issued and outstanding
Cash = 2,010,293
Total Liabilities = 900,244
They should utilize that rich cash reserve in the form of a one-time-dividend to light a fire under some apathetic kiesters? $.25 cents, $.50 cents even better...
CPSS 8.69 - sold 1/2 my poke at 8.65 with intent to rebuy any potential dip. Anyone else have thoughts?
NXTC 6.19 - 8.86 BV (mostly cash)...pps getting tortured. News out over the weekend...is there anything to like here?
https://docoh.com/filing/1661059/0001104659-21-139169/NXTC-8K/file/2
SNFCA 8.92 - Q3 filed with what I think are exceptional numbers for a $9 pps stock but wtfdik cause no one else seems to care???
Scott M. Quist, President of the Company, said, "Realizing our operational earnings decreased as compared to 2020, I am nevertheless very proud of the results for Quarter 3 and year-to-date 2021. I believe our financial results represent a very solid performance by our teams accomplished despite a continuingly difficult operational environment. Every business segment delivered impressive results.
https://docoh.com/news/benzinga/24100551/security-national-financial?fromCompany=318673